Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Cell Division

Figure 3

From: Therapeutic targeting of cancer cell cycle using proteasome inhibitors

Figure 3

Proteasome inhibitor induced ROS generation and cell cycle arrest. Proteasome inhibitors increase the endogenous level of reactive oxygen species which causes DNA damage by inducing double strand breaks in intact DNA. PIs treatment leads to accumulation of p53 which senses this DNA damage. p53 reactivation upregulates p21 expression, a CDK inhibitor. p21 binds and inactivates Cyclin B and CDK2 and causes G2/M cell cycle arrest in response to PIs.

Back to article page